New vaccine aims to protect against deadly plague
NCT ID NCT07207408
Summary
This study is testing a new vaccine designed to prevent pneumonic plague, a severe lung infection caused by bacteria. Researchers will give the vaccine to about 148 healthy adults aged 18-55 to see how well their immune systems respond and to check for side effects. The goal is to find the safest and most effective dose and schedule for future use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREVENTION OF PNEUMONIC PLAGUE RESULTING FROM AEROSOL EXPOSURE TO YERSENIA PESTIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AMR- El Dorado
RECRUITINGEl Dorado, Kansas, 67042, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
AMR- Las Vegas
RECRUITINGLas Vegas, Nevada, 889119, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
AMR- Miami
NOT_YET_RECRUITINGMiami, Florida, 33134, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.